Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients

Allergy. 2023 Mar;78(3):875-878. doi: 10.1111/all.15591. Epub 2022 Dec 3.

Authors

Lotte S Spekhorst¹, Lisa P van der Rijst¹, Marlies de Graaf¹, Maxime van Megen¹, Nicolaas P A Zuithoff², André C Knulst¹, Marjolein S de Bruin-Weller¹, Thuy-My Le¹

Affiliations

¹ National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
² Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 36420598
DOI: 10.1111/all.15591

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Allergens
Dermatitis, Atopic* / drug therapy
Food Hypersensitivity* / drug therapy
Humans
Immunoglobulin E

Substances

dupilumab
Allergens
Immunoglobulin E